# ClinicalTrials.gov record NCT06348264

> PeptideScanner retained ClinicalTrials.gov record NCT06348264 at 2026-07-30T18:22:04.916Z. Its registry update date was 2025-09-23, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct06348264-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-09-23
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06348264-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06348264-leuprolide-v1.json
- Content SHA-256: `ccddc3d753056d32b7da411fe97f7a00c41ffe36ecf50eb7aa1a000db5c4a80d`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06348264 ([`ctg-observation-nct06348264-2025-09-23-37f0bb7adf2e`](#source-ctg-observation-nct06348264-2025-09-23-37f0bb7adf2e))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06348264 at 2026-07-30T18:22:04.916Z. Its registry update date was 2025-09-23, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct06348264-2025-09-23-37f0bb7adf2e`](#source-ctg-observation-nct06348264-2025-09-23-37f0bb7adf2e))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06348264 at 2026-07-30T18:22:04.916Z. Its registry update date was 2025-09-23, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct06348264-2025-09-23-37f0bb7adf2e`](#source-ctg-observation-nct06348264-2025-09-23-37f0bb7adf2e))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06348264-2025-09-23-37f0bb7adf2e`](#source-ctg-observation-nct06348264-2025-09-23-37f0bb7adf2e))

## Sources

<a id="source-ctg-observation-nct06348264-2025-09-23-37f0bb7adf2e"></a>
- **ClinicalTrials.gov record NCT06348264 · retained source version 2025-09-23:37f0bb7adf2e06e712cf5c30973196d05264b47c956da2f30e7761493615a69b** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06348264) (`ctg-observation-nct06348264-2025-09-23-37f0bb7adf2e`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06348264." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06348264-leuprolide-v1.json SHA-256: ccddc3d753056d32b7da411fe97f7a00c41ffe36ecf50eb7aa1a000db5c4a80d.